BioMarin Pharmaceutical
BMRN
#1907
Rang
€8.81 Md
Capitalisation boursière
45,87 €
Prix de l'action
-0.78%
Changement (1 jour)
-26.62%
Changement (1 an)

BioMarin Pharmaceutical (BMRN) - Dette totale

Dette totale au bilan au Septembre 2025 : 0.51 Milliard d'euros

Selon les derniers rapports financiers de BioMarin Pharmaceutical, la dette totale de l'entreprise est de 0.51 Milliard d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

BioMarin Pharmaceutical - Dette totale au bilan (de 1999 à 2025)

Dette totale par année

Année Dette totale Changement
2024-12-31€0.57 Md-41.57%
2023-12-31€0.99 Md-2.76%
2022-12-31€1.01 Md5.95%
2021-12-31€0.96 Md8.87%
2020-12-31€0.88 Md15.26%
2019-12-31€0.76 Md5.61%
2018-12-31€0.72 Md-25.84%
2017-12-31€0.97 Md50.69%
2016-12-31€0.64 Md7.24%
2015-12-31€0.60 Md14.59%
2014-12-31€0.52 Md11.36%
2013-12-31€0.47 Md80.32%
2012-12-31€0.26 Md-1.85%
2011-12-31€0.26 Md-5.5%
2010-12-31€0.28 Md-18.2%
2009-12-31€0.34 Md-14.58%
2008-12-31€0.40 Md19.24%
2007-12-31€0.34 Md94.81%
2006-12-31€0.17 Md-7.63%
2005-12-31€0.18 Md-5.18%
2004-12-31€0.19 Md101.1%
2003-12-31€99.28 M
2001-12-31€6.28 M7035.33%
2000-12-31€0.08 M-20.13%
1999-12-31€0.11 M30.9%
1998-12-31€0.08 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Ultragenyx Pharmaceutical
RARE
€29.05 M-94.40%🇺🇸 USA
Sangamo Therapeutics
SGMO
€21.83 M-95.79%🇺🇸 USA
Esperion Therapeutics
ESPR
€0.26 Md-49.23%🇺🇸 USA
Sanofi
SNY
€21.92 Md 4,125.35%🇫🇷 France
Amicus Therapeutics
FOLD
€0.38 Md-26.71%🇺🇸 USA
Catalyst Pharmaceuticals
CPRX
€2.48 M-99.52%🇺🇸 USA